Pyxis Oncology, Inc. — Investor Relations & Filings
Pyxis Oncology, Inc. is a clinical-stage company focused on developing next-generation therapeutics for difficult-to-treat cancers. The company's differentiated portfolio of clinical assets is centered on two primary modalities: antibody-drug conjugates (ADCs) and immuno-oncology (IO). Its ADC technology platform is designed to deliver potent cancer-killing agents directly to tumor cells for enhanced safety and efficacy. The immuno-oncology programs utilize monoclonal antibodies (mAbs) to mobilize the body's immune system to attack cancer cells by blocking tumor defense mechanisms and overcoming immune suppression. Pyxis Oncology is advancing its product candidates as both monotherapies and in combination with other therapies to improve outcomes for patients with solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| ARS - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| DEF 14A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| 8-K/A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | |
| 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 45988994 | 10-Q | 2026-05-14 | English | ||
| 45977153 | 8-K | 2026-05-14 | English | ||
| 39075634 | ARS - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 39073772 | DEF 14A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 39069707 | 8-K/A - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-04-30 | English | ||
| 33043094 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33043082 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33042858 | 4 - Pyxis Oncology, Inc. (0001782223) (Issuer) | 2026-03-25 | English | ||
| 33012784 | 10-K - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-03-23 | English | ||
| 33012771 | 8-K - Pyxis Oncology, Inc. (0001782223) (Filer) | 2026-03-23 | English | ||
| 31693671 | SCHEDULE 13G/A Filing | 2026-02-09 | English | ||
| 31693670 | 8-K Filing | 2026-02-06 | English | ||
| 31693678 | 4 Filing | 2026-02-05 | English | ||
|
2025
2 filings
| |||||
| 13190750 | 8-K | 2025-12-18 | English | ||
| 13190751 | Regulatory Filings 2025 | 2025-12-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
Pyxis Oncology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33976/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33976 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33976 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33976 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33976}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pyxis Oncology, Inc. (id: 33976)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.